本研究针对扩张型心肌病（DCM）患者冠状动脉微循环功能障碍（CMD）的预后评估难题，通过结合晚期钆增强（LGE）与血管造影衍生微循环阻力指数（angio-IMR），发现两者联合可显著预测3年内全因死亡率或心衰住院风险（HR 12.20），为DCM精准分层提供新策略。

Final data from 93-patient Phase 2a clinical trial show lower annualized rate of vaso-occlusive crises (VOCs) and longer time to first VOC on IMR-687 Interim open-label extension clinical trial data ...

Oral presentation provides first look at new program, IMR-261, a novel, oral, clinic-ready nuclear factor erythroid 2-related factor 2 (Nrf2) activator SCD Townes mouse model demonstrates IMR-261 ...

Final data from 93-patient Phase 2a clinical trial show lower annualized rate of vaso-occlusive crises (VOCs) and longer time to first VOC on IMR-687 Interim open-label extension clinical trial data ...